DMTF1

Across TCGA pan-cancer cohorts, DMTF1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DMTF1 data layer compared with 30 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher DMTF1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DMTF1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

BRCA, UCEC, and THYM are the cancer types where DMTF1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.064	0.924	<.001	48	view →
UCEC	OS	Median	II,III,IV	1.000	0.452	.004	36	view →
THYM	OS	Median	All	0.068	0.977	<.001	24	view →
CESC	OS	Median	II,III,IV	0.175	0.765	<.001	14	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DMTF1–BRCA (OS)

Open the BRCA breakdown →